Dr. Julio Chavez, MD

• Medical Oncology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• CAR T cell therapy for B-cell lymphomas, 2018-04-11

• Editorial: Advances in the treatment of primary central nervous system lymphoma, 2023-08-14

• Patterns and Predictors of Failure in Recurrent or Refractory Large B-Cell Lymphomas After Chimeric Antigen Receptor T-Cell Therapy, 2021-07-06

• Cardiovascular Events Among Adults Treated with Chimeric Antigen Receptor T-Cells (CAR-T), 2019-12-24

• Phase Ib study of avadomide (CC-122) in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma, 2022-02-14

• Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial, 2022-03-21

• Diffuse large B-cell lymphoma with primary treatment failure: Ultra-high risk features and benchmarking for experimental therapies, 2017-06-28

• Selected Domains within a Comprehensive Geriatric Assessment in Older Patients with Non-Hodgkin Lymphoma are Highly Associated with Frailty, 2022-05-11

• Genomic aberrations deletion 11q and deletion 17p independently predict for worse progression-free and overall survival after allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia, 2014-04-28

• Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell Lymphoma, 2019-06-05

• Obinutuzumab as bridging therapy for successful manufacturing of axicabtagene ciloleucel for transformed follicular lymphoma with circulating cells, 2019-06-18

• Radiotherapy for early stage diffuse large B-cell lymphoma with or without double or triple hit genetic alterations, 2018-11-20

• Phase Ib study of combinations of avadomide (CC-122), CC-223, CC-292, and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma, 2022-01-14

• Impact of oncogene rearrangement patterns on outcomes in double-hit non-Hodgkin lymphoma patients, 2015-11-13

• Change in patients' perceived cognition following chimeric antigen receptor T-cell therapy for lymphoma, 2022-05-14

• Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial, 2018-12-02

• Prevalence of cutaneous viral infections in incident cutaneous squamous cell carcinoma detected among chronic lymphocytic leukemia and hematopoietic stem cell transplant patients, 2017-07-06

• Change in neurocognitive performance among patients with non-Hodgkin's lymphoma in the first year after CAR T-cell therapy, 2022-04-01

• Association between immunoglobulin heavy-chain variable region mutational status and isolated favorable baseline genomic aberrations in chronic lymphocytic leukemia, 2017-06-22

• Allogeneic hematopoietic cell transplantation is an effective treatment for patients with Richter syndrome: A systematic review and meta-analysis, 2020-05-15

• Outcomes of CD19 CAR T cell therapy in patients with gastrointestinal tract involvement of large B cell lymphoma, 2021-05-30

• Tumor Microenvironment composition and severe cytokine release syndrome (CRS) Influence Toxicity in Patients with Large B Cell Lymphoma Treated with Axicabtagene Ciloleucel, 2020-07-15